Cytometry News and Research

RSS
New blood test provides fast, accurate diagnosis of tuberculosis in children

New blood test provides fast, accurate diagnosis of tuberculosis in children

High PD-L1 expression linked to reduced survival in NSCLC

High PD-L1 expression linked to reduced survival in NSCLC

CD157 important in malignant pleural mesothelioma

CD157 important in malignant pleural mesothelioma

Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Beckman Coulter Life Sciences launches Aquios CL Clinical Flow Cytometer* for laboratory use

Beckman Coulter Life Sciences launches Aquios CL Clinical Flow Cytometer* for laboratory use

Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

Six-way jet-in-air sorter from Beckman Coulter Life Sciences delivers simultaneous high-speed cell sorting and sub-micron particle detection

Six-way jet-in-air sorter from Beckman Coulter Life Sciences delivers simultaneous high-speed cell sorting and sub-micron particle detection

Stowers team reports genome-wide analysis of genes that drive cell division in multicellular organism

Stowers team reports genome-wide analysis of genes that drive cell division in multicellular organism

Beckman Coulter Life Sciences’ Avanti centrifuges combine high performance and application versatility

Beckman Coulter Life Sciences’ Avanti centrifuges combine high performance and application versatility

New research may open door to novel therapies for treating immune disorders

New research may open door to novel therapies for treating immune disorders

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

Merck Millipore announces joint development agreement with Sysmex Corporation

Merck Millipore announces joint development agreement with Sysmex Corporation

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Quintiles named ‘Best CRO in Asia’ for third time in event's four-year history

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Beckman Coulter Life Sciences announces agreement with Wyatt Technology Corporation

Phasefocus’ KTP associate Dr Suman receives runners up spot for Cellular Heaven and Hell time-lapse video

Phasefocus’ KTP associate Dr Suman receives runners up spot for Cellular Heaven and Hell time-lapse video

Study shows how immune system reconstitutes itself following immune-depleting therapy

Study shows how immune system reconstitutes itself following immune-depleting therapy

Virtual Lens series of label-free live cell imaging systems announced by Phasefocus

Virtual Lens series of label-free live cell imaging systems announced by Phasefocus

Phasefocus reports on new ptychography paper published in Nature Scientific Reports

Phasefocus reports on new ptychography paper published in Nature Scientific Reports

Study ultimately could lead to development of screening test for diagnosing bladder cancer

Study ultimately could lead to development of screening test for diagnosing bladder cancer

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

Pharmacyclics presents ibrutinib trial data for B-cell malignancies at ASH meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.